A pharmaceutical research company focused on developing nanocarriers that can deliver therapeutics to anatomically difficult to reach sites. Using these novel nanocarriers, Eira Biotech aims to treat inner-ear neuronal degeneration, improving outcomes for patients with a permanent hearing loss.